Cargando…
Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway
Globally, lung cancer remains one of the most prevalent malignant cancers. However, molecular mechanisms and functions involved in its pathogenesis have not been clearly elucidated. This study aimed to evaluate the specific regulatory mechanisms of exosomal miR-338-3p/CHL1/MAPK signaling pathway axi...
Autores principales: | Tian, Wen, Yang, Xianglin, Yang, He, Lv, Meiwen, Sun, Xinran, Zhou, Baosen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557210/ https://www.ncbi.nlm.nih.gov/pubmed/34718336 http://dx.doi.org/10.1038/s41419-021-04314-2 |
Ejemplares similares
-
Correction: Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway
por: Tian, Wen, et al.
Publicado: (2022) -
Molecular interactions of miR-338 during tumor progression and metastasis
por: Moghbeli, Meysam
Publicado: (2021) -
miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells
por: Chen, Jing-Song, et al.
Publicado: (2016) -
CHL1 gene polymorphisms increase lung cancer susceptibility
por: Tian, Wen, et al.
Publicado: (2018) -
miR-338-3p suppresses the malignancy of T-cell lymphoblastic lymphoma by downregulating HOXA3
por: Wang, Li, et al.
Publicado: (2019)